PE20060723A1 - Derivados de morfina como agentes analgesicos - Google Patents

Derivados de morfina como agentes analgesicos

Info

Publication number
PE20060723A1
PE20060723A1 PE2005001291A PE2005001291A PE20060723A1 PE 20060723 A1 PE20060723 A1 PE 20060723A1 PE 2005001291 A PE2005001291 A PE 2005001291A PE 2005001291 A PE2005001291 A PE 2005001291A PE 20060723 A1 PE20060723 A1 PE 20060723A1
Authority
PE
Peru
Prior art keywords
alcoxy
morphinan
ona
cyclopropylmethyl
dihydroxy
Prior art date
Application number
PE2005001291A
Other languages
English (en)
Inventor
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PE20060723A1 publication Critical patent/PE20060723A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C5), CICLOALQUILALQUILO(C4-C7), ENTRE OTROS; R2 Y R3 SON H, HIDROXI, ALCOXI(C1-C5), ENTRE OTROS; X ES ALQUILENO(C2-C7), ALQUENILENO(C2-C7), ALQUINILENO(C2-C7); Y ES C(=O), C(=S), S(O), ENTRE OTROS; k ES DE 0 A 8; R5 ES FLUOR, CLORO, BROMO, ENTRE OTROS; R10 ES H, ALQUILO(C1-C5), ALQUENILO(C2-C5), ENTRE OTROS; R11 ES H; R12 ES H, HIDROXI, ALCOXI(C1-C5), ENTRE OTROS; R13 ES H; R14 ES H, HIDROXI, ALCOXI(C1-C5). SON COMPUESTOS PREFERIDOS: [1-(17-CICLOPROPILMETIL-4,5a-EPOXI-3,14-DIHIDROXI-MORFINAN-6a-IL)PIRROLIDIN-2-ONA, [1-(17-CICLOPROPILMETIL-4,5a-EPOXI-3,14-DIHIDROXI-MORFINAN-6b-IL)-3-BENCIL-PIRROLIDIN-2-ONA, [2-(17-CICLOPROPILMETIL-4,5 a-EPOXI-3,14-DIHIDROXI-MORFINAN-6b-IL)-2,3-DIHIDRO-ISOINDOL-1-ONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON DERIVADOS DE MORFINA UTILES EN EL TRATAMIENTO DEL DOLOR AGUDO Y CRONICO
PE2005001291A 2004-11-04 2005-11-03 Derivados de morfina como agentes analgesicos PE20060723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04

Publications (1)

Publication Number Publication Date
PE20060723A1 true PE20060723A1 (es) 2006-08-29

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001291A PE20060723A1 (es) 2004-11-04 2005-11-03 Derivados de morfina como agentes analgesicos

Country Status (13)

Country Link
US (1) US8470845B2 (es)
EP (1) EP1820505A4 (es)
JP (1) JP4706636B2 (es)
KR (1) KR101285645B1 (es)
CN (1) CN101090722B (es)
AR (1) AR053098A1 (es)
CA (1) CA2586181C (es)
HK (1) HK1115808A1 (es)
MX (1) MX2007005336A (es)
NO (1) NO20072832L (es)
PE (1) PE20060723A1 (es)
TW (1) TW200621785A (es)
WO (1) WO2006049248A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080065664A (ko) 2005-11-09 2008-07-14 도레이 가부시끼가이샤 기능성 장장해의 치료 또는 예방제
AU2006328765B2 (en) * 2005-12-21 2012-01-12 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
JP5321454B2 (ja) * 2007-05-21 2013-10-23 東レ株式会社 医薬錠剤の製造法
EP2168579B1 (en) * 2007-05-21 2017-10-11 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in dissolution property and chemical stability of oral preparation
KR101546398B1 (ko) * 2007-05-21 2015-08-26 도레이 카부시키가이샤 결정성 미분화 입자
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
EP3761982B1 (en) 2018-03-08 2024-10-09 Victoria Link Ltd Use of nalfurafine for the treatment of demyelinating diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (es) * 1964-02-03 1966-10-31
US3318886A (en) 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
WO1995003308A1 (en) 1993-07-23 1995-02-02 Toray Industries, Inc. Morphinan derivative and medicinal use
WO1996027375A2 (en) 1995-03-03 1996-09-12 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
CN1374963A (zh) 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
DE60109960T2 (de) 2000-10-31 2006-02-16 Rensselaer Polytechnic Institute 8-substituierte 2,6-methano-3-benzazocine und 3-substituierte morphinane als opioidrezeptorbindende agenzien
JP4016986B2 (ja) 2002-10-09 2007-12-05 東レ株式会社 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
EP1736157B1 (en) 2004-03-30 2008-11-19 Toray Industries, Inc. Morphinan derivatives as anti-itching agent

Also Published As

Publication number Publication date
NO20072832L (no) 2007-08-01
JP4706636B2 (ja) 2011-06-22
KR20070085436A (ko) 2007-08-27
WO2006049248A1 (ja) 2006-05-11
US20070299100A1 (en) 2007-12-27
EP1820505A1 (en) 2007-08-22
TWI356826B (es) 2012-01-21
MX2007005336A (es) 2007-06-25
CN101090722A (zh) 2007-12-19
TW200621785A (en) 2006-07-01
HK1115808A1 (en) 2008-12-12
EP1820505A4 (en) 2010-01-20
CA2586181C (en) 2012-11-27
CA2586181A1 (en) 2006-05-11
KR101285645B1 (ko) 2013-07-12
CN101090722B (zh) 2011-12-21
AR053098A1 (es) 2007-04-25
JPWO2006049248A1 (ja) 2008-08-07
US8470845B2 (en) 2013-06-25

Similar Documents

Publication Publication Date Title
PE20060723A1 (es) Derivados de morfina como agentes analgesicos
PE20110568A1 (es) Agentes terapeuticos 414
PE20120355A1 (es) DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
PE20011119A1 (es) Composiciones farmaceuticas de agonista/antagonista de estrogenos para el tratamiento de afecciones que responden a un aumento de testosterona
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
SE0200979D0 (sv) New compounds
PE20071061A1 (es) Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf)
PE20110390A1 (es) Composicion de tapentadol y un antagonista opioide
PE20010925A1 (es) Compuestos inhibidores del neuropeptido y utiles para el tratamiento de la disfuncion sexual femenina
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20020573A1 (es) Derivados glucopiranosiloxibencilbenceno, composiciones farmaceuticas que los comprenden e intermedios de los mismos
CR10167A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor"
PE20060186A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparacion asi como su uso como medicamento
PE20110222A1 (es) Inhibidores de dipeptidilpeptidasa iv
ECSP088863A (es) Compuestos que son agonistas de receptores muscarínicos y que pueden ser eficaces en el tratamiento del dolor, la enfermedad de alzheimer y/o la esquizofrenia
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
PE20030497A1 (es) Combinaciones de un inhibidor de pde 5 y otros agentes activos
PE20061049A1 (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida como antagonistas del receptor de vanilloides tipo 1 (vr1)
PE20081596A1 (es) Derivados fluorinados de deferiprona
AR059501A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida
RU2007128080A (ru) Производные пирролидиния в качестве мускариновых рецепторов мз
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
PE20050732A1 (es) Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos

Legal Events

Date Code Title Description
FC Refusal